Estrogen and mechanical forces are positive regulators for osteoblast proliferation and bone formation. We investigated the synergistic effect of estrogen and flow-induced shear stress on signal transduction and gene expression in human osetoblast-like MG63 cells and primary osteoblasts (HOBs) using activations of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) and expressions of c-fos and cyclooxygenase-2 (I) as readouts. Estrogen (17b-estradiol, 10 nM) and shear stress ( 
Introduction
M echanical loading is essential for maintaining skeletal integrity and bone mass.
(1) Suppression of this stimulus under conditions such as long-term bed rest and space flight results in bone loss and even osteoporosis. (2) During dynamic loading of intact bone, interstitial fluid (ISF) flow through the canaliculi generates shear stress that is detected by bone cells, including osteoblasts. (3) It has been shown that fluid shear stress regulates signaling, gene expression, proliferation, and differentiation in osteoblasts. (4) Recent studies using flow channels demonstrated that application of fluid shear stress to osteoblasts induces their expression of many genes, including transcription factor c-fos 5 and cyclooxygenase-2 (Cox-2), (5) both of which have been shown to play important roles in bone formation in vivo. (6, 7) In addition to mechanical forces, estrogen, a major sex steroid hormone in female, has been shown to induce osteoblast proliferation and bone formation, with suppression in bone tissue resorption by decreasing osteoclast activity. (8) A deficiency of estrogen accelerates bone lose; this is probably the major reason leading to osteoporosis in menopausal women. (9) 17b-showed that 17b-estradiol induces insulin-like growth factor 1 (IGF-1) and alkaline phosphatase (ALP) production through estrogen receptors (ERs) to increase osteoblast proliferation and bone formation. (10, 11) Blockage of ERs by the specific ER antagonist ICI 182,780 inhibited 17b-estradiol-induced IGF-1 and ALP productions by osteoblasts. (10, 11) In addition, estrogen has been shown to inhibit osteoblast and osteocyte apoptosis and promote the survival of these cells, which contributes to the beneficial effect of the steroids in bone. (12) (13) (14) Although both estrogen and mechanical force have been shown to be positive regulators for osteoblast proliferation and bone formation, whether they play synergistic roles in modulating signaling and gene expression in osteoblasts remains unclear.
Integrins, as the main receptors that connect the cytoskeleton and the extracellular matrix (ECM), have been shown to play important roles in transmitting mechanical stresses into chemical signals in a wide variety of cells seeded on the ECM. (15) Human osteoblasts express several types of integrins, including those containing the b 1 subunit (dimerized with a subunits, including a 1 , a 3 , a 5 , and a 6 ), (16) which have been
shown to play important roles in osteoblast differentiation and commitment. (17) In several systems, including endothelial cells, shear stress activation of integrins leads to an increase in their association with an adaptor protein, Shc, that subsequently activates the downstream mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK) and p38 MAPK. (18) Recent studies demonstrated that estrogen induces b 1 -integrin expression and adhesive properties in endothelial cells. (19) Although integrins have been well recognized as mechanosensors in a variety of cells in response to mechanical stimuli, whether estrogen regulates mechanical responsiveness of signaling and gene expression in osteoblasts by modulating their integrin expression remains unclear.
In this study, we investigated the synergistic role of estrogen and shear stress in signaling and gene expression in both human osteoblast-like MG63 cells and primary osteoblasts (HOBs) using activations of ERK and p38 MAPK and expressions of c-fos and Cox-2 as readouts. MG63 cells were derived originally from an osteogenic sarcoma of a 14-year-old boy and exhibit many osteoblast traits characteristic of bone-forming cells. (20) Our results showed that pretreatment of MG63 cells and HOBs with 17b-estradiol enhances shear stress-induced activations of ERK and p38 MAPK and expressions of c-fos and Cox-2 through ER-mediated increases in b 1 -integrin expression. Our findings provide insights into the mechanism by which estrogen augments shear stress responsiveness of signal transduction and bone-formation-related gene expression in bone cells via ER-mediated induction of b 1 -integrin.
Materials and Methods

Materials
Mouse monoclonal antibodies (mAbs) against ERK2 (sc-1647) and phospho-ERK1/2 (sc-7383) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibody (pAb) against p38 MAPK and mouse mAb against phospho-p38 MAPK were purchased from Cell Signaling Technology (Beverly, MA, USA). Mouse mAb against human b 1 -integrin was purchased from Chemicon (MAB 2253, Temecula, CA, USA 
Cell culture
The human osteoblast-like MG63 cells were obtained from American Type Culture Collection (Rockville, MD, USA) and cultured in a phenol red-free medium (a-MEM, Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS, Gibco). Human bone specimens were collected aseptically during orthopedic surgery of the knee or the hip, and the primary HOBs were harvested and cultured by using the method described previously. (10) Osteocalcin expression and alkaline phosphatase activity were examined to confirm the osteoblastic phenotype of HOBs. The HOBs were cultured in a phenol redfree medium (DMEM, Gibco) supplemented with 20% FBS. After reaching confluence, these cells were trypsinized and seeded onto glass slides (75 Â 38 mm, Corning Incorporated, Corning, NY, USA) that had been precoated with type I collagen (30 mg/ mL) at a concentration of 10 4 cells/cm 2 . The cells were incubated in phenol red-free a-MEM supplemented with 10% FBS (pretreated with charcoal to remove endogenous estrogen in the serum) for 24 hrs. The medium then was changed to phenol red-and serum-free a-MEM containing 0.25% bovine serum albumin (BSA) for incubating the cells for 48 hrs prior to the experiments.
Flow apparatus
The slide with cultured MG63 cells or HOBs was mounted in a parallel-plate flow chamber, which has been characterized and described in detail elsewhere. (21) The chamber was connected to a perfusion loop system, kept in a constant temperaturecontrolled enclosure, and maintained at pH 7.4 by continuous gassing with humidified 5% CO 2 in air. The flow channel width (w) was 1 cm, and the channel height (h) was 0.025 cm. The fluid shear stress (t) generated on the cells by flow was calculated to be 12 dyn/cm 2 , using the formula t ¼ 6mQ/wh 2 , where m is the dynamic viscosity of the perfusate and Q is the flow rate. In some experiments, MG63 cells or HOBs were incubated with the specific inhibitor for ERs (ICI 182,780, 10 nM), ERK (PD98059, 30 mM), or p38 MAPK (SB203580, 10 mM) for 1 hr before stimulation with 17b-estradiol (10 nM) or exposure to flow.
Western blot analysis
The cells were lysed with a buffer containing 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and a protease inhibitor mixture (PMSF, aprotinin, and sodium orthovanadate). The total cell lysate (100 mg of protein) was separated by SDS-PAGE (12% running, 4% stacking) and analyzed by using the designated antibodies and the Western-Light chemiluminescent detection system (Applied Biosystems, Foster City, CA, USA), as described previously. (21) RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR) Quantitative real-time PCR
The cDNA was amplified through PCR on a LightCycler (Roche Diagnostics, East Sussex, United Kingdom) using LightCycler FastStart DNA MasterPlus SYBR Green I (Roche Diagnostics) with 0.5 mM primers of c-fos and Cox-2 genes (see Table 1 ). PCR was performed in triplicate at 958C for 10 minutes, followed by 45 cycles of denaturation at 958C for 10 seconds, annealing at 608C for 5 seconds, extension at 728C for 8 seconds, and single signal acquisition for 10 seconds. The b-actin gene expression was used as an internal control. The PCR conditions were optimized to obtain a PCR product with a single peak on melting-curve analysis on the LightCycler. Raw data collected from the LightCycler were analyzed using LightCycler Software Version 3.5 (Roche Diagnostics). The c-fos and Cox-2 gene expression levels were normalized with b-actin gene expression level in the same sample.
Flow cytometric analysis 
Results
Estrogen augments shear stress-induced ERK and p38 MAPK phosphorylations in MG63 cells
We first examined the individual effects of estrogen and shear stress on the activations of ERK and p38 MAPK in MG63 cells. MG63 cells were stimulated with 17b-estradiol (10 nM) for 5, 15, and 30 minutes and 1, 3, and 6 hours, and their phosphorylations of ERK and p38 MAPK were determined by Western blot analysis. As shown in Figure 1A , stimulation of MG63 cells with 17b-estradiol induced a rapid increase (significant within 5 minutes) in the ERK phosphorylation in these cells. In contrast, the increase in p38 MAPK phosphorylation induced by 17b-estradiol was later (significant within 1 hour). These increased levels of ERK and p38 MAPK phosphorylations decreased to nearly the basal levels 30 minutes and 6 hrs, respectively, after 17b-estradiol stimulation. Application of shear stress (12 dyn/cm 2 ) to MG63 
cells induced a rapid increase (significant within 10 minutes) in ERK and p38 MAPK phosphorylations in comparison with static controls (see Fig. 1B ). These increased levels of ERK and p38 MAPK phosphorylations decreased to nearly the basal levels 30 minutes and 1 hour, respectively, after exposure to flow.
To investigate the synergistic effect of estrogen and shear stress on the ERK and p38 MAPK activations, MG63 cells were treated with 17b-estradiol for 6 hrs and then exposed to flow for 10 minutes in the presence of 17b-estradiol. The activations of ERK and p38 MAPK in these cells were compared with those in the cells stimulated with 17b-estradiol and shear stress alone. As shown in Fig. 1C , pretreatment of MG63 cells with 17b-estradiol before exposure to shear stress resulted in higher levels of ERK and p38 MAPK phosphorylations in these cells than in the cells exposed to shear stress alone. These results suggest that pretreatment of MG63 cells with estrogen before shearing augments the shear stress-induced ERK and p38 MAPK phosphorylations in these cells. This augmented effect of estrogen on shear stress-induced ERK and p38 MAPK phosphorylations was not seen in cells exposed to simultaneous stimuli with shear stress and 17b-estradiol for 10 minutes in the absence of 17b-estradiol pretreatment (see Fig. 1D ).
Estrogen Estrogen-mediated augmentation of shear stressinduced ERK and p38 MAPK activations in MG63 cells is mediated by ERs through b 1 -integrin Given our findings that estrogen augments shear stress-induced ERK and p38 MAPK activations in MG63 cells and that estrogen induces b 1 -integrin expression through ERs, we investigated whether the augmented effect of estrogen on shear stressinduced ERK and p38 MAPK activations is mediated by ERs through b 1 -integrin. To this end, MG63 cells were kept as controls or pretreated with ICI 182,780 for 1 hr and then stimulated with 17b-estradiol for 6 hours, followed by exposure to shear stress at 12 dyn/cm 2 for 10 minutes. As shown in (Fig. 4A) within 15 minutes. For 1 hr of testing, the longer the duration of shearing, the greater was the increase in Cox-2 mRNA expression. In contrast, the increased expression of c-fos mRNA declined but still elevated after 1 hr of flow application. Pretreating MG63 cells with specific inhibitor of either ERK (e.g., PD98059; 30 mM) or p38 MAPK (i.e., SB203580; 10 mM) or the combination of both inhibitors resulted in inhibitions, at least in part, in shear stressinduced c-fos and Cox-2 expressions (see Fig. 4B ), indicating that both ERK and p38 are involved in shear stress inductions of these two bone-formation-related genes in MG63 cells. The expressions of c-fos and Cox-2 in MG63 cells were induced by treating with 17b-estradiol alone within 30 minutes (Fig. 4C) . These increased levels of c-fos and Cox-2 mRNAs were declined to the basal levels 3 hours after 17b-estradiol stimulation. 3 . Estrogen-mediated augmentation of shear stress-induced ERK and p38 MAPK activations in MG63 cells is regulated by ERs and b 1 -integrin. MG63 cells were kept as controls or pretreated with ICI 182,780 (ICI; 1 mM) for 1 hr and then stimulated with 17b-estradiol (E 2 ; 10 nM) for 6 hrs, followed by exposure to shear stress (S; 12 dyn/cm 2 ) for 10 minutes (E 2 þ S) (A). In parallel experiments, MG63 cells were transfected with control (siCL) or b 1 -integrinspecific siRNA (sib 1 ) for 48 hours prior to 17b-estradiol and shear stress stimuli (B). (C) Cells were transfected with control or b 1 -integrin-specific siRNA for 48 hrs and then kept as controls or treated with 17b-estradiol for 15 minutes (for ERK) or 1 hr (for p38 MAPK). The phosphorylations of ERK and p38 MAPK in these cells were determined by Western blot analysis. Data are presented as the amounts (band densities normalized to the total protein levels) of phosphorylated ERK and p38 MAPK proteins relative to those in static control cells pretreated with vehicle control (A) or transfected with control siRNA (B, C) and are shown as mean AE SEM from three independent experiments.
To investigate the synergistic effect of estrogen and shear stress on the expressions of c-fos and Cox-2, MG63 cells were treated with 17b-estradiol for 6 hrs and then exposed to flow for 15 minutes (for c-fos) or 1 hr (for Cox-2). Pretreatment of MG63 cells with 17b-estradiol before shearing resulted in an augmentation of shear stress-induced c-fos and Cox-2 expressions compared with cells exposed to flow in the absence of 17b-estradiol pretreatment (Fig. 4D) . However, this estrogen augmentation of shear stress-induced c-fos and Cox-2 expressions was not seen in cells exposed to simultaneous stimuli with shear stress and 17b-estradiol for 15 and 30 minutes in the absence of 17b-estradiol pretreatment (see Fig. 4E ). Pretreating In some experiments, MG63 cells were pretreated with vehicle control DMSO or specific inhibitor of ERK (PD98058; 30 mM) or p38 MAPK (SB203580; 10 mM) or a combination of these inhibitors for 1 hr before exposure to shear stress for 15 minutes (for c-fos) or 1 hour (for Cox-2) (B).
In parallel experiments, the cells were stimulated with 17b-estradiol for 6 hrs and then exposed to shear stress for 15 minutes (for c-fos) or 1 hour (for Cox-2) (E 2 þ S) (D). Prior to 17b-estradiol and shear stress treatments, the cells were preincubated with PD98058 or SB203580 or a combination of these inhibitors for 1 hour ( F). (E) MG63 cells were subjected to simultaneous stimuli with shear stress and 17b-estradiol for 15 MG63 cells with either PD98059 (30 mM) or SB203580 (10 mM) or a combination of these inhibitors abolished the estrogen augmentation of shear stress-induced c-fos and Cox-2 expressions (see Fig. 4F ), suggesting that the augmented effect of estrogen on shear induction of c-fos and Cox-2 in MG63 cells is mediated by the ERK and p38 MAPK pathways.
The estrogen augmention of shear stress-induced c-fos and Cox-2 expressions is mediated by ERs through b 1 -integrin MG63 cells were kept as controls or pretreated with ICI 182,780 for 1 hr and then stimulated with 17b-estradiol for 6 hrs, followed by exposure to shear stress at 12 dyn/cm 2 for 15 minutes (for cfos) or 1 hour (for Cox-2). The expressions of the c-fos and Cox-2 genes in these cells were examined by quantitative real-time PCR. Application of shear stress to MG63 cells induced their c-fos and Cox-2 mRNA expressions (Fig. 5A ). These shear stressinduced expressions of mRNAs were augmented by pretreating the cells with 17b-estradiol before shearing. Pretreating MG63 cells with ICI 182,780 before 17b-estradiol and shear stress stimuli resulted in inhibitions in the augmented effect of 17b-estradiol on shear inductions of c-fos and Cox-2 but did not affect the induction of these genes by shear stress (as compared with the application of shear stress alone). In parallel experiments, MG63 cells were transfected with control or b 1 -specific siRNA (40 nM) and then treated with 17b-estradiol for 6 hours, followed by exposure to shear stress for 15 minutes (for c-fos) or 1 hour (for Cox-2). As shown in Fig. 5B , transfection of MG63 cells with b 1 -specific siRNA (compared with control siRNA) inhibited not only the shear inductions of c-fos and Cox-2 but also the augmentation effect of 17b-estradiol on shear inductions of these genes. Taken together with our findings that estrogen induces b 1 -integrin expression through ERs, these results suggest that the augmentation effect of estrogen on shear inductions of c-fos and Cox-2 in MG63 cells is mediated by ERs through b 1 -intergrin.
Confirmation of the augmented effect of estrogen on shear-induced signaling and gene expression in primary HOBs
Since MG63 cells are a highly transformed cell line derived originally from an osteogenic sarcoma (despite sharing some properties characterized for osteoblasts), we examined whether similar results on the effect of estrogen on shear-induced signaling and gene expression in MG63 cells can be obtained with primary HOBs. As shown in Figure 6 , HOBs pretreated with 17b-estradiol for 6 hours with subsequent exposure to shear stress had higher levels of ERK and p38 MAPK phosphorylations (see Fig. 6A ) and c-fos and Cox-2 expressions (see Fig. 6B ) than the cells exposed to shear stress alone. Treating HOBs with 17b-estradiol for 6 hours resulted in an increase in b 1 -integrin surface expression; this estrogen induction of b 1 -integrin was inhibited by pretreating the cells with ICI 182,780 (see Fig. 6C ). Moreover, transfecting HOBs with b 1 -specific siRNA (compared with control siRNA; 40 nM for each) resulted in inhibitions, at least in part, in shear-induced ERK and p38 MAPK phosphorylations (see Fig. 6D ) and c-fos and Cox-2 expressions (see Fig. 6E ), as well as the 17b-estradiol-mediated augmentation of these shear-induced MAPK signaling and gene expressions in these cells. However, in contrast to MG63 cells, HOBs transfected with b 1 -specific siRNA had higher basal levels of MAPK signaling and c-fos and Cox-2 expressions than the control siRNA-transfected cells. These results confirm the role of estrogen in modulating shear stressinduced signaling and gene expression through ER induction of b 1 -integrin in primary HOBs.
Discussion
The aim of this study was to investigate the synergistic role of estrogen and shear stress in signal transduction and gene expression in human osteoblast-like MG63 cells and primary 
studies, we have demonstrated that estrogen augments the shear stress-induced ERK and p38 MAPK activations and c-fos and Cox-2 expressions in osteoblast-like cells through ER-mediated increases in b 1 -integrin expression. Several lines of evidence support this conclusion. First, MG63 cells treated with 17b-estradiol for 6 hrs followed by exposure to shear stress had higher levels of ERK and p38 MAPK phosphorylations and c-fos and Cox-2 expressions than the cells exposed only to shear stress without 17b-estradiol pretreatment. Second, MG63 cells stimulated with 17b-estradiol for 6 hours had higher levels of b 1 -integrin mRNA and protein expressions than the unstimulated cells. Blockage of ERs by the ER-specific antagonist ICI 182,780 inhibited the 17b-estradiol-induced b 1 -integrin expression in MG63 cells. Third, pretreating MG63 cells with ICI 182,780 or transfecting the cells with b 1 -specific siRNA inhibited the augmentation effects of 17b-estradiol on shear stress-induced ERK and p38 MAPK phosphorylations and c-fos and Cox-2 expressions in MG63 cells. Fourth, similar results on the augmented effect of estrogen on MAPK signaling and c-fos and Cox-2 expressions were obtained using HOBs. Our findings provide insights into the mechanism by which estrogen and shear stress play synergistic roles in modulating signaling and gene expression in osteoblast-like cells.
Both estrogen and mechanical forces have been shown to be positive regulators for osteoblast proliferation and bone formation. (22) (23) (24) (25) However, the synergistic roles of these two stimulators in modulating signaling and gene expression in osteoblasts remain unclear. Jagger and colleagues (26) demonstrated that estrogen administration augments compressive force-induced osteogenic response in rat caudal vertebrae. Joldersma and colleagues (27) showed that estrogen enhances shear stress-induced production of prostaglandin E 2 (PGE 2 ) by osteoblasts derived from postmenopausal and nonosteoporotic women. Bakker and colleagues (28) showed that estrogen and shear stress exert additive effects on the productions of PGE 2 and nitric oxide by bone cells derived from osteoporotic women (aged 62-90 years). These results suggest that estrogen may affect the signaling and function of bone cells in response to mechanical forces, which consequently may affect the mechanoresponsiveness of bone in the process of bone formation and remodeling. In this study, we demonstrated for the first time that pretreatment of osteoblast-like MG63 cells and HOBs with estrogen augments the shear stress-induced ERK and p38 MAPK phosphorylations and c-fos and Cox-2 expressions. These results indicate that estrogen may regulate mechanosensitivity of bone cells via the MAPK pathway, which may result in the increased expression of bone-formation-related genes, for example, c-fos and Cox-2, and the consequent modulation in bone formation and remodeling in response to mechanical stimuli. Several studies have indicated that ERs may play important roles in bone formation and adaptation in response to mechanical forces. (29) (30) (31) Lee and colleagues (29) applied mechanical strain to the ulnae of ERa knockout (ERa À/À ) mice and found that the strain-induced bone formation of cortical bone in ERa À/ À mice is only one-third of that in ERa þ/þ littermates. They further demonstrated that osteoblast-like cells derived from ERa À/À mice have deficient response to mechanical strain. (30) Damien and colleagues (31) showed that mechanical strain stimulates osteoblast proliferation through ERs in males as well as females. Aguirre and colleagues (32) (34) demonstrated that the effect of mechanical stretch on osteocytic cells can be transmitted by integrins, which are required for mechanical stretch-induced activation of ERK that plays important roles against cell apoptosis induced by different stimuli. In vascular endothelial cells, estrogen has been shown to induce b 1 -integrin expression and hence cell attachment and migration, which consequently may promote neovascularization and vessel repair. (19) This may be the reason for the observation that women prior to menopause have a lower cardiovascular risk but a higher incidence of several blood vessel-related autoimmune diseases, including Takayasu arteritis and systemic lupus erythematosus, than men. (35) (36) (37) The results of our present study showed that estrogen can induce the mRNA and protein expressions of b 1 -integrin in osteoblast-like MG63 cells and HOBs, in addition to endothelial cells. This estrogen-induced expression of b 1 -integrin requires ERs and contributes to the augmentation effects of estrogen on shear stress-induced ERK and p38 MAPK signaling and c-fos and Cox-2 expressions in these osteoblast-like cells and HOBs. These results suggest that b 1 -integrin plays an important role in the modulation of signaling and gene expression in osteoblastic cells in response to the synergistic interaction of chemical and mechanical stimuli, for example, estrogen and shear stress. In this study, shear stress was applied to the cells at the time point where the effects of estrogen on MAPK signaling and c-fos and Cox-2 gene expressions have subsided (i.e., 6 hours of 17b-estradiol pretreatment before shearing). This treatment schedule allows us to clarify whether estrogen could exert effects on shear stress-induced signaling and gene expression even though its individual effect has disappeared. To elucidate whether the effect of shear stress still could be enhanced by estrogen applied together with shear stress without pretreatment, MG63 cells were subjected to shear stress in the presence of 17b-estradiol for 10 minutes (for MAPK) and 15 and 30 minutes (for c-fos and Cox-2), and the results showed that simultaneous stimuli with shear stress and estrogen did not result in an augmentation in shear stress-induced MAPK signaling (see Fig. 1D ) and gene expression (see Fig. 4E ) in MG63 cells compared with cells exposed to shear stress alone. The lack of an augmented effect of estrogen on shear stress-induced signaling and gene expression in these experiments could be due to the short exposure times (i.e., 10, 15, and 30 minutes), where the b 1 -integrin protein expression has not been induced by estrogen.
The proto-oncogene c-fos has been shown to be involved in mitogenic responses of osteoblastic cells. (38) Stable expression of c-fos in mice has been demonstrated in developing bones, cartilages, and teeth. (39) Overexpression of c-fos in transgenic and chimeric mice enhances bone and cartilage development. (40) In contrast, homozygous c-fos À/À mice are growthretarded and develop osteopetrosis, with deficiencies in bone remodeling and tooth eruption, compared with normal littermates. (41) Recent studies have demonstrated that estrogen induces c-fos expression in rat bone. (42) In addition, mechanically induced bone formation has been shown to be preceded by the expression of c-fos in the whole animal. (43) These results suggest that c-fos protein may serve as a critical molecule for bone formation and development and that c-fos expression may be affected by estrogen and mechanical forces in vivo. Cox-2 is a rate-limiting enzyme in the conversion of membrane-related arachidonic acid to prostaglandins to mediate the stimulatory effects of estrogen and mechanical loading on bone formation. (44, 45) Cox-2 -/-mice have decreased bone density in comparison with normal littermates. (46) Bending forces applied to the tibiae of rats were found to increase Cox-2 and c-fos mRNA expressions in vivo. (46) These reports suggest that the expressions of c-fos and Cox-2 may play significant roles in estrogenand mechanical loading-induced bone formation and remodeling. In this study, we demonstrated that both estrogen and mechanical forces can induce c-fos and Cox-2 expressions in osteoblast-like cells. Our study further demonstrated that estrogen and shear stress can exert additive effects on the induction of c-fos and Cox-2 expressions in osteoblast-like cells, suggesting that estrogen and mechanical forces may play synergistic roles in the process of bone formation and remodeling. Deficiency in estrogen has been shown to be a risk factor to induce osteoporosis in postmenopausal women. Recent studies demonstrated that osteoblasts derived from osteoporotic patients showed less adhesive ability and lower levels of integrin/adhesion-mediated signaling activation than the cells derived from nonosteoporotic patients. (47) It is possible that the estrogen-less condition in postmenopausal women may result in a reduction in mechanical sensitivity of osteoblasts by decreasing the expression of integrins and the activation of integrin/ adhesion-mediated signaling events, which consequently may influence the formation and remodeling of bone in response to mechanical stimuli. In summary, this study demonstrated for the first time that estrogen augments the shear stress-induced MAPK signaling and c-fos and Cox-2 expressions in human osteoblast-like MG63 cells and primary osteoblasts. This estrogen-induced augmentation of signaling and gene expression in response to shear stress is mediated by ERs through increased expression of b 1 -integrin. The identification of this synergistic role of estrogen and shear stress in modulating signaling and gene expression in osteoblasic cells not only provides new insights into the mechanism by which chemical stimuli may influence mechanical responses of bone cells but also aids in the future development of bone tissue engineering and pharmacologic therapies to increase bone formation.
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